PaxMedica, Inc. Common Stock
PXMD
PXMD was delisted on the 1st of May, 2024.
12 hedge funds and large institutions have $96.7K invested in PaxMedica, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
50% more funds holding
Funds holding: 8 → 12 (+4)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
42% less capital invested
Capital invested by funds: $165K → $96.7K (-$68.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$55.3K |
| 2 |
CA
Clearstead Advisors
Cleveland,
Ohio
|
+$43.5K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$17.7K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.14K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$629 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$54.2K |
| 2 |
HF
HRT Financial
New York
|
-$8.65K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $28K | +$55.3K | +5,712 | New |
|
|
CA
2
Clearstead Advisors
Cleveland,
Ohio
| $21.8K | +$43.5K | +4,489 | New |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $15.7K | – | – | – |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $9.22K | +$17.7K | +1,826 | New |
|
5
Geode Capital Management
Boston,
Massachusetts
| $9.14K | – | – | – |
|
6
State Street
Boston,
Massachusetts
| $6.5K | – | – | – |
|
|
HF
7
HRT Financial
New York
| $3K | -$8.65K | -894 | -59% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $2.25K | +$77 | +8 | +2% |
|
|
9
Osaic Holdings
Scottsdale,
Arizona
| $572 | +$1.14K | +118 | New |
|
|
10
UBS Group
Zurich,
Switzerland
| $314 | +$629 | +65 | New |
|
11
Bank of America
Charlotte,
North Carolina
| $143 | – | – | – |
|
12
Wells Fargo
San Francisco,
California
| $10 | – | – | – |
|
13
JP Morgan Chase
New York
| $1 | – | – | – |
|
|
14
Citadel Advisors
Miami,
Florida
| – | -$54.2K | -4,058 | Closed |
|
PXMD Hedge Fund Activity: Q3 2023 in Review
12 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in PaxMedica, Inc. Common Stock (PXMD) for Q3 2023, worth a combined $96.7K — down 42% from $165K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PXMD positions and 1 closed out — a net gain of 4 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $55.3K. The largest seller was Citadel Advisors, exiting entirely with an estimated $54.2K sold.
- 12 institutional investors held PaxMedica, Inc. Common Stock (PXMD) as of Q3 2023, up from 8 in Q2 2023.
- Funds reported $96.7K of PaxMedica, Inc. Common Stock stock for Q3 2023, down 42% quarter-over-quarter.
- 5 funds opened new PaxMedica, Inc. Common Stock positions in Q3 2023 and 1 closed out, a net change of +4 holders.
- The largest PaxMedica, Inc. Common Stock buyer in Q3 2023 was Renaissance Technologies, an estimated $55.3K added.
- The largest PaxMedica, Inc. Common Stock seller in Q3 2023 was Citadel Advisors, an estimated $54.2K sold.
Based on aggregated 13F filings for Q3 2023.